- Home
- PTGX vs HTH Comparison
PTGX vs HTH Comparison
Compare PTGX & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTGX | HTH |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 2.1B |
| IPO Year | 2016 | 2003 |
Fundamental Metrics
Financial Performance| Metric | PTGX | HTH |
|---|---|---|
| Price | $98.51 | $35.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 2 |
| Target Price | ★ $106.67 | $37.50 |
| AVG Volume (30 Days) | ★ 811.3K | 320.9K |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.25% |
| EPS Growth | N/A | ★ 51.72 |
| EPS | N/A | ★ 2.64 |
| Revenue | N/A | ★ $152,188,000.00 |
| Revenue This Year | $867.86 | N/A |
| Revenue Next Year | N/A | $3.22 |
| P/E Ratio | ★ N/A | $13.49 |
| Revenue Growth | N/A | ★ 15.52 |
| 52 Week Low | $39.60 | $27.35 |
| 52 Week High | $105.69 | $40.41 |
Technical Indicators
Market Signals| Indicator | PTGX | HTH |
|---|---|---|
| Relative Strength Index (RSI) | 56.73 | 41.04 |
| Support Level | $76.63 | $33.79 |
| Resistance Level | $100.00 | $35.69 |
| Average True Range (ATR) | 4.71 | 0.71 |
| MACD | 0.12 | 0.03 |
| Stochastic Oscillator | 53.74 | 38.86 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The company has three segments: The banking segment includes the operations of the Bank; The broker-dealer segment includes the operations of Securities Holdings,; and the mortgage origination segment is composed of PrimeLending. Majority of revenue is from Broker-dealer Segment.